Your browser doesn't support javascript.
loading
The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
François, Violaine; Ottaviani, Sabrina; Renkvist, Nicolina; Stockis, Julie; Schuler, Gerold; Thielemans, Kris; Colau, Didier; Marchand, Marie; Boon, Thierry; Lucas, Sophie; van der Bruggen, Pierre.
Affiliation
  • François V; Université Catholique de Louvain, Ludwig Institute for Cancer Research Ltd, Vrije Universiteit Brussel, Brussels, Belgium.
Cancer Res ; 69(10): 4335-45, 2009 May 15.
Article in En | MEDLINE | ID: mdl-19435913

Full text: 1 Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / T-Lymphocytes, Regulatory / Cancer Vaccines / Vaccines, Subunit / Melanoma / Antigens, Neoplasm / Neoplasm Proteins Limits: Humans Language: En Year: 2009 Type: Article

Full text: 1 Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / T-Lymphocytes, Regulatory / Cancer Vaccines / Vaccines, Subunit / Melanoma / Antigens, Neoplasm / Neoplasm Proteins Limits: Humans Language: En Year: 2009 Type: Article